About Promea Therapeutics
Promea Therapeutics is a Healthcare company based in Patancheruvu (India) founded in 2017 by Pooja Aakanksha Gaddam and Rajesh Tummuru. Life science products and diagnostics are manufactured by the company. The company has 174 employees. Its Indian entity Promea Therapeutics Private Limited reported revenue of ₹56.78 Cr. Its focus areas include Diversified Medical Devices and Devices.
Company details
Promea Therapeutics was founded in 2017 and is based in Patancheruvu, India. Operations focus on the production of medical products within the life sciences sector, including diagnostics for clinical chemistry, immunodiagnostics, and molecular diagnostics, as well as infusion therapies. These offerings support healthcare applications through established manufacturing processes in the region.
- Headquarters Patancheruvu, India
- Employees 174
- Founders Pooja Aakanksha Gaddam, Rajesh Tummuru
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website promea.in
- Social LinkedIn X Facebook
- Legal Name Promea Therapeutics Private Limited
- Date of Incorporation 31 Jul, 2017
- Jurisdiction Patancheru, Telangana, India
- Annual Revenue₹56.78 Cr
FY 2023 · +98% YoY
- Net Loss-₹1.17 Cr
FY 2023 · -2% margin
- EBITDA₹11.38 Cr
FY 2023 · 20% margin
- Employee Count174
Associated legal entities of Promea Therapeutics
Promea Therapeutics operates through Promea Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Promea Therapeutics Private Limited CIN U24304TG2017PTC118617 | Active | 31 Jul 2017 | Patancheru, Telangana | ₹56.8 Cr | 174 | 2 | View details |
Board of directors of Promea Therapeutics Private Limited (Promea Therapeutics)
Promea Therapeutics Private Limited is the primary company behind Promea Therapeutics. The board of Promea Therapeutics Private Limited currently have 2 directors; the longest-serving is Pooja Aakanksha Gaddam, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pooja Aakanksha Gaddam DIN 07440198 | Director | 31 Jul 2017 | 9 yrs 3 mo | Promea Therapeutics Private Limited |
| Rajesh Reddy Tummuru DIN 05346342 | Director | 09 Oct 2017 | 9 yrs | Promea Therapeutics Private Limited |
People of Promea Therapeutics
12 people are tracked at Promea Therapeutics (5 in leadership, 7 in team); the tracked headcount is 174.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
Madhava Rao | Director MSAT - Plant Head Biologics | Leadership |
Nayan Bhatt | Assistant General Manager | Leadership |
Muppidi Srikanth | Export Head | Creating Strategic Growth For Promea Therapeutics | Leadership |
Priyajit Saha | Project Manager | Team |
Prasad Kammampati | Executive-hr&admin | Team |
Swati Kumari | Jr.executive | Team |
Naren Goud | Senior Executive | Team |
Ritika Singh | Executive Assistant | Team |
Kranti Patil | Research Associate | Team |
Satain Bhat | National Service Manager | Team |
Complete people profiles for Promea Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Promea Therapeutics
Figures of Promea Therapeutics Private Limited, the primary company behind Promea Therapeutics, for FY 2023. Revenue was ₹56.78 Cr (+98% year on year). Net loss was -₹1.17 Cr (-2% margin). EBITDA was ₹11.38 Cr (20% margin). Revenue has grown at a compounded annual rate of +60% over three years and +95% over five years.
- ₹56.78 CrRevenue · FY 2023 · +98% YoY
- -₹1.17 CrNet loss · -2% margin
- ₹11.38 CrEBITDA · 20% margin
- ₹3.86 CrPaid-up capital
- 174Employees (provident fund records)
- +60%Revenue CAGR, 3 years
- +95%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Promea Therapeutics Private Limited are on its company page.
Detailed financial statements for Promea Therapeutics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Promea Therapeutics
The website of Promea Therapeutics (promea.in) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 28.3% vs previous month
Websites whose visitors overlap most with Promea Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| teemv.in | 100% | View details | |||
f7healthcare.com | f7healthcare.com | 98% | #14,180,574 | – | |
shivammedicalequipments.com | shivammedicalequipments.com | 97% | – | ||
| genesismedicals.com | 91% | View details | |||
| mediblueworld.in | 90% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Promea Therapeutics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Promea Therapeutics
Promea Therapeutics was founded in 2017.
Promea Therapeutics is headquartered in Patancheruvu, India. It is registered at Patancheruvu, Telangana, India.
Promea Therapeutics has 174 employees.
The primary company behind Promea Therapeutics, Promea Therapeutics Private Limited, reported revenue of ₹56.78 Cr for FY 2023, up 98% year on year.
Promea Therapeutics was founded in 2017 and is based in Patancheruvu, India. Operations focus on the production of medical products within the life sciences sector, including diagnostics for clinical chemistry, immunodiagnostics, and molecular diagnostics, as well as infusion therapies. These offerings support healthcare applications through established manufacturing processes in the region.
Promea Therapeutics operates through Promea Therapeutics Private Limited.
The legal entities of Promea Therapeutics currently have 2 directors, including Rajesh Reddy Tummuru, Pooja Aakanksha Gaddam.